SLC2A1 and Dravet syndrome: Based on the growing evidence of the therapeutic role of KDTs for neurological diseases and on the protective effect of the MD, it would be of great importance to delineate a Mediterranean version of this high-fat therapy in order to maintain its high ketogenic ratio and avoid side effects, especially in patients requiring long-term treatment (i.e., GLUT1-DS patients).